Impact Events
MoreDate | Lead Company | Event | Type | Approval Change | Approval Likelihood |
---|---|---|---|---|---|
10/16/24 | Merck (MRK) | Capvaxive for Pneumococcal (Streptococcus pneumoniae) Vaccines (Antibacterial) | Subscribers Only | Subscribers Only | Subscribers Only |
10/15/24 | Amgen (AMGN) | Uplizna for Myasthenia Gravis (MG) | Subscribers Only | Subscribers Only | Subscribers Only |
10/15/24 | Jazz (JAZZ) | Zepzelca for Small Cell Lung Cancer (SCLC) | Subscribers Only | Subscribers Only | Subscribers Only |
10/14/24 | GSK (GSK) | Depemokimab for Chronic Rhinosinusitis | Subscribers Only | Subscribers Only | Subscribers Only |
10/10/24 | Stealth Biotherapeutics | Elamipretide (Systemic Delivery) for Cardiomyopathy - Dilated | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
MoreExpected Date Range | Lead Company | Drug | Expected Catalyst |
---|---|---|---|
09/12/2024 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
09/30/2024 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
10/16/2024 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
Now - 10/18/2024 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
Now - 10/18/2024 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |